adagrasib,Pembrolizumab
mirati,merck
['nsclc', 'sclc', 'ca,022,i', 'ca,022,1', 'lung', 'mirati']
very much looking forward to the details of this dataset later today #esmoimmuno22. will have lots of implications for the sector and frontline development of kras-specific inhibitors whatever the data shows. 
Thoracic Oncologist @royalmarsdenNHS, Professor @ICR_London; Chair @BTOGorg; views are my own.